Aethlon Medical, Inc. (AEMD) stock has gained 396.21% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives AEMD stock a score of 68 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 100. AEMD's rank also includes a long-term technical score of 99. The fundamental score for AEMD is 4. In addition to the average rating from Wall Street analysts, AEMD stock has a mean target price of 6.333. This means analysts expect the stock to lose 3.31% over the next 12 months.
What's Happening with AEMD Stock Today
Aethlon Medical, Inc. (AEMD) stock has fallen -5.07% while the S&P 500 has gained 0.13% as of 9:54 AM on Friday, Jun 11. AEMD has fallen -$0.35 from the previous closing price of $6.90 on volume of 1,715,396 shares. Over the past year the S&P 500 is higher by 41.40% while AEMD has gained 396.21%. AEMD lost -$0.71 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Aethlon Medical, Inc. (AEMD) Stock.
